SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathwayBrian J. Willett, James Austin, Patawee Asamaphan et al.|Nature Microbiology|2022Cited by 724
Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunityEmma C. Thomson, Gyorgy Snell, Massimo Galli et al.|Cell|2021Cited by 656
Reduced neutralisation of the Delta (B.1.617.2) SARS-CoV-2 variant of concern following vaccinationChristopher Davis|PLoS Pathogens|2021Cited by 195
Genomic epidemiology reveals multiple introductions of SARS-CoV-2 from mainland Europe into ScotlandAna da Silva Filipe, David L. Robertson, James G. Shepherd et al.|Nature Microbiology|2020Cited by 129
SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccinationFelicity Liew, Meera Chand, Shubha Talwar et al.|EBioMedicine|2022Cited by 121